Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17317 | 541 | 26.1 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
707 | 12199 | STREPTOMYCES//ISOPENICILLIN N SYNTHASE//STREPTOMYCES CLAVULIGERUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACTINOSYNNEMA PRETIOSUM | Author keyword | 27 | 92% | 2% | 11 |
2 | ANSAMITOCINS | Author keyword | 23 | 100% | 2% | 10 |
3 | ANSAMITOCIN | Author keyword | 15 | 88% | 1% | 7 |
4 | ANSAMITOCIN P 3 | Author keyword | 15 | 88% | 1% | 7 |
5 | TRIENE ANSAMYCIN | Author keyword | 12 | 86% | 1% | 6 |
6 | RIFAMYCIN B | Author keyword | 7 | 67% | 1% | 6 |
7 | DIVERGOLIDES | Author keyword | 6 | 80% | 1% | 4 |
8 | RIFAMYCIN OXIDASE | Author keyword | 6 | 100% | 1% | 4 |
9 | AMYCOLATOPSIS MEDITERRANEI | Author keyword | 5 | 36% | 2% | 12 |
10 | MAYTANSINOIDS | Author keyword | 5 | 63% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACTINOSYNNEMA PRETIOSUM | 27 | 92% | 2% | 11 | Search ACTINOSYNNEMA+PRETIOSUM | Search ACTINOSYNNEMA+PRETIOSUM |
2 | ANSAMITOCINS | 23 | 100% | 2% | 10 | Search ANSAMITOCINS | Search ANSAMITOCINS |
3 | ANSAMITOCIN | 15 | 88% | 1% | 7 | Search ANSAMITOCIN | Search ANSAMITOCIN |
4 | ANSAMITOCIN P 3 | 15 | 88% | 1% | 7 | Search ANSAMITOCIN+P+3 | Search ANSAMITOCIN+P+3 |
5 | TRIENE ANSAMYCIN | 12 | 86% | 1% | 6 | Search TRIENE+ANSAMYCIN | Search TRIENE+ANSAMYCIN |
6 | RIFAMYCIN B | 7 | 67% | 1% | 6 | Search RIFAMYCIN+B | Search RIFAMYCIN+B |
7 | DIVERGOLIDES | 6 | 80% | 1% | 4 | Search DIVERGOLIDES | Search DIVERGOLIDES |
8 | RIFAMYCIN OXIDASE | 6 | 100% | 1% | 4 | Search RIFAMYCIN+OXIDASE | Search RIFAMYCIN+OXIDASE |
9 | AMYCOLATOPSIS MEDITERRANEI | 5 | 36% | 2% | 12 | Search AMYCOLATOPSIS+MEDITERRANEI | Search AMYCOLATOPSIS+MEDITERRANEI |
10 | MAYTANSINOIDS | 5 | 63% | 1% | 5 | Search MAYTANSINOIDS | Search MAYTANSINOIDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTITUMOR AGENT ANSAMITOCIN | 45 | 83% | 5% | 25 |
2 | ACTINOSYNNEMA PRETIOSUM | 44 | 81% | 5% | 26 |
3 | MYCOTRIENIN ANTIBIOTICS | 35 | 86% | 3% | 18 |
4 | TRIENOMYCIN A | 31 | 82% | 3% | 18 |
5 | MAYTANSINOID TUMOR INHIBITORS | 27 | 92% | 2% | 11 |
6 | 3 AMINO 5 HYDROXYBENZOIC ACID | 26 | 48% | 7% | 40 |
7 | MC7N UNITS | 21 | 75% | 3% | 15 |
8 | ANSAMYCIN ANTIBIOTICS | 21 | 61% | 4% | 22 |
9 | MAYTANSINOID ANTIBIOTICS | 15 | 82% | 2% | 9 |
10 | MYCOTRIENIN I | 11 | 78% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recent developments in the maytansinoid antitumor agents | 2004 | 139 | 123 | 57% |
The biosynthesis of 3-amino-5-hydroxybenzoic acid (AHBA), the precursor of mC(7)N units in ansamycin and mitomycin antibiotics: a review | 2011 | 24 | 53 | 64% |
Biosynthesis of 3,5-AHBA-derived natural products | 2012 | 12 | 119 | 48% |
From ergot to ansamycins-45 years in biosynthesis | 2006 | 19 | 32 | 44% |
Natural products derived from unusual variants of the shikimate pathway | 1997 | 62 | 103 | 34% |
Design and synthesis of ansamycin antibiotics | 2008 | 20 | 133 | 30% |
Rifamycin-mode of action, resistance, and biosynthesis | 2005 | 144 | 78 | 19% |
Lessons from the rifamycin biosynthetic gene cluster | 1999 | 44 | 24 | 38% |
BIOTRANSFORMATIONS OF RIFAMYCINS - PROCESS POSSIBILITIES | 1992 | 7 | 11 | 100% |
RIFAMYCINS - STRAIN IMPROVEMENT PROGRAM | 1995 | 10 | 22 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUER PHARMAZEUT BIOL | 1 | 50% | 0.2% | 1 |
2 | MBI CHAIR MARINE BIOSCI | 1 | 50% | 0.2% | 1 |
3 | MICOBACTERIAS BIOL MOL | 1 | 50% | 0.2% | 1 |
4 | WIRKSTOFFZENTRUM | 1 | 50% | 0.2% | 1 |
5 | ZENTRUM BIOMOL WIRKSTOFFCHEM | 1 | 50% | 0.2% | 1 |
6 | BIOMOL DRUG BMWZ | 1 | 13% | 0.7% | 4 |
7 | ADV CATALYSIS SYNTH | 1 | 22% | 0.4% | 2 |
8 | TECHNOL PROC | 0 | 11% | 0.7% | 4 |
9 | O BIOTECNOL | 0 | 20% | 0.4% | 2 |
10 | CHEM BIOL ENGN ERI | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000174249 | RIFAMPICIN INACTIVATION//FOURIER TRANSFORM ION CYCLOTRON ONANCE IL//HELMHOLTZ INFECT DIS |
2 | 0.0000141575 | BISORBICILLINOIDS//TRICHODERMA SP USF 2690//DPPH RADICAL SCAVENGER |
3 | 0.0000134281 | PHARMACEUT SCI KITA 12 NISHI 6 KITA KU//PHARMACEUT SCI KITA 12 NISHI6 KITA KU//CHIRAL CYCLOPENTANES |
4 | 0.0000114006 | POLYKETIDE SYNTHASES//POLYKETIDES//POLYKETIDE |
5 | 0.0000079472 | DHMEQ//SCYPHOSTATIN//EPOXYQUINOL |
6 | 0.0000072532 | ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1 |
7 | 0.0000069116 | BREFELDIN C//LETOSTEINE//BREFELDIN A ANALOGUES |
8 | 0.0000061702 | ALICYCLOBACILLUS ACIDOTERRESTRIS//ALICYCLOBACILLUS//ALICYCLOBACILLUS SPP |
9 | 0.0000059954 | VICENISTATIN//IODO DEBORONATION//CHLORO DEBORONATION |
10 | 0.0000059433 | 2 DEOXY SCYLLO INOSOSE SYNTHASE//BUTIROSIN//STREPTOMYCES KANAMYCETICUS |